278 related articles for article (PubMed ID: 11079736)
1. Rationale for the luminal provision of butyrate in intestinal diseases.
Wächtershäuser A; Stein J
Eur J Nutr; 2000 Aug; 39(4):164-71. PubMed ID: 11079736
[TBL] [Abstract][Full Text] [Related]
2. Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implications.
Velázquez OC; Lederer HM; Rombeau JL
Adv Exp Med Biol; 1997; 427():123-34. PubMed ID: 9361838
[TBL] [Abstract][Full Text] [Related]
3. Review article: the role of butyrate on colonic function.
Hamer HM; Jonkers D; Venema K; Vanhoutvin S; Troost FJ; Brummer RJ
Aliment Pharmacol Ther; 2008 Jan; 27(2):104-19. PubMed ID: 17973645
[TBL] [Abstract][Full Text] [Related]
4. Short-chain fatty acid (SCFA) uptake into Caco-2 cells by a pH-dependent and carrier mediated transport mechanism.
Stein J; Zores M; Schröder O
Eur J Nutr; 2000 Jun; 39(3):121-5. PubMed ID: 10918994
[TBL] [Abstract][Full Text] [Related]
5. Increasing butyrate concentration in the distal colon by accelerating intestinal transit.
Lewis SJ; Heaton KW
Gut; 1997 Aug; 41(2):245-51. PubMed ID: 9301506
[TBL] [Abstract][Full Text] [Related]
6. Dietary resistant starch and chronic inflammatory bowel diseases.
Jacobasch G; Schmiedl D; Kruschewski M; Schmehl K
Int J Colorectal Dis; 1999 Nov; 14(4-5):201-11. PubMed ID: 10647628
[TBL] [Abstract][Full Text] [Related]
7. Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo-oligosaccharides, in dextran sulfate sodium-induced experimental colitis.
Moreau NM; Martin LJ; Toquet CS; Laboisse CL; Nguyen PG; Siliart BS; Dumon HJ; Champ MM
Br J Nutr; 2003 Jul; 90(1):75-85. PubMed ID: 12844378
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids.
Kripke SA; Fox AD; Berman JM; Settle RG; Rombeau JL
JPEN J Parenter Enteral Nutr; 1989; 13(2):109-16. PubMed ID: 2496241
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-chain fatty acids on the inflamed colonic mucosa.
Scheppach W; Christl SU; Bartram HP; Richter F; Kasper H
Scand J Gastroenterol Suppl; 1997; 222():53-7. PubMed ID: 9145448
[TBL] [Abstract][Full Text] [Related]
10. Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation.
Bach Knudsen KE; Lærke HN; Hedemann MS; Nielsen TS; Ingerslev AK; Gundelund Nielsen DS; Theil PK; Purup S; Hald S; Schioldan AG; Marco ML; Gregersen S; Hermansen K
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30322146
[TBL] [Abstract][Full Text] [Related]
11. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.
Canani RB; Costanzo MD; Leone L; Pedata M; Meli R; Calignano A
World J Gastroenterol; 2011 Mar; 17(12):1519-28. PubMed ID: 21472114
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus GG and tributyrin supplementation reduce antibiotic-induced intestinal injury.
Cresci G; Nagy LE; Ganapathy V
JPEN J Parenter Enteral Nutr; 2013 Nov; 37(6):763-74. PubMed ID: 23630018
[TBL] [Abstract][Full Text] [Related]
13. Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources.
Beyer-Sehlmeyer G; Glei M; Hartmann E; Hughes R; Persin C; Böhm V; Rowland I; Schubert R; Jahreis G; Pool-Zobel BL
Br J Nutr; 2003 Dec; 90(6):1057-70. PubMed ID: 14641965
[TBL] [Abstract][Full Text] [Related]
14. Psyllium shifts the fermentation site of high-amylose cornstarch toward the distal colon and increases fecal butyrate concentration in rats.
Morita T; Kasaoka S; Hase K; Kiriyama S
J Nutr; 1999 Nov; 129(11):2081-7. PubMed ID: 10539788
[TBL] [Abstract][Full Text] [Related]
15. Effects of dietary fiber on inflammatory bowel disease.
Galvez J; Rodríguez-Cabezas ME; Zarzuelo A
Mol Nutr Food Res; 2005 Jun; 49(6):601-8. PubMed ID: 15841496
[TBL] [Abstract][Full Text] [Related]
16. Histological changes in the colonic mucosa following irrigation with short-chain fatty acids.
Scheppach W; Müller JG; Boxberger F; Dusel G; Richter F; Bartram HP; Christl SU; Dempfle CE; Kasper H
Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):163-8. PubMed ID: 9058627
[TBL] [Abstract][Full Text] [Related]
17. Role of short-chain fatty acids in the hind gut.
von Engelhardt W; Bartels J; Kirschberger S; Meyer zu Düttingdorf HD; Busche R
Vet Q; 1998; 20 Suppl 3():S52-9. PubMed ID: 9689727
[TBL] [Abstract][Full Text] [Related]
18. Abnormal absorptive colonic motor activity in germ-free mice is rectified by butyrate, an effect possibly mediated by mucosal serotonin.
Vincent AD; Wang XY; Parsons SP; Khan WI; Huizinga JD
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G896-G907. PubMed ID: 30095295
[TBL] [Abstract][Full Text] [Related]
19. Short-chain fatty acid induces intestinal mucosal injury in newborn rats and down-regulates intestinal trefoil factor gene expression in vivo and in vitro.
Lin J; Peng L; Itzkowitz S; Holzman IR; Babyatsky MW
J Pediatr Gastroenterol Nutr; 2005 Nov; 41(5):607-11. PubMed ID: 16254517
[TBL] [Abstract][Full Text] [Related]
20. Cellular and physiological effects of short-chain fatty acids.
Miller SJ
Mini Rev Med Chem; 2004 Oct; 4(8):839-45. PubMed ID: 15544545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
